bioAffinity Technologies Inc

BIAF04 Dec 2024
Healthcare
$1.12
-0.03 (-2.65%)
Lowest Today
$1.1
Highest Today
$1.17
Today’s Open
$1.12
Prev. Close
$1.13
52 Week High
$3.62
52 Week Low
$1.03
To Invest in bioAffinity Technologies Inc

bioAffinity Technologies Inc

Healthcare
BIAF04 Dec 2024
-0.03 (-2.65%)
1M
3M
6M
1Y
5Y
Low
$1.1
Day’s Range
High
$1.17
1.1
52 Week Low
$1.03
52-Week Range
52 Week High
$3.62
1.03
1 Day
-
1 Week
-4.23%
1 month return
-18.11%
3 month return
-18.11%
6 month return
-50.65%
1 Year return
-29.81%
3 Years return
-
5 Years return
-
10 Years return
-
Institutional Holdings
Vanguard Group Inc
1.67
Vanguard Total Stock Mkt Idx Inv
1.41
Geode Capital Management, LLC
0.56
Fidelity Extended Market Index
0.31
Vanguard Institutional Extnd Mkt Idx Tr
0.26
CapTrust Financial Advisors
0.18
Sheaff Brock Investment Advisors, LLC
0.13

Market Status

Fundamentals
Market Cap
19.81 mln
PB Ratio
5.64
PE Ratio
0
Enterprise Value
18.57 mln
Total Assets
8.22 mln
Volume

Company Financials

Fund house & investment objective

Company Information
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.
Organisation
bioAffinity Technologies Inc
Employees
75
Industry
Diagnostics & Research
CEO
Ms. Maria  Zannes J.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step